Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

Tannaz Eslamparast; Hossein Poustchi; Farhad Zamani; Maryam Sharafkhah; Reza Malekzadeh; Azita Hekmatdoost

doi:10.3945/ajcn.113.068890

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

American Journal of Clinical Nutrition ◽

10.3945/ajcn.113.068890 ◽

2014 ◽

Vol 99 (3) ◽

pp. 535-542 ◽

Cited By ~ 162

Author(s):

Tannaz Eslamparast ◽

Hossein Poustchi ◽

Farhad Zamani ◽

Maryam Sharafkhah ◽

Reza Malekzadeh ◽

...

Keyword(s):

Liver Disease ◽

Pilot Study ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Double Blind ◽

Nonalcoholic Fatty Liver ◽

Double Blind Placebo ◽

Synbiotic Supplementation

Download Full-text

Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Hepatitis Monthly ◽

10.5812/hepatmon.34897 ◽

2016 ◽

Vol 16 (1) ◽

Cited By ~ 36

Author(s):

Mehran Rahimlou ◽

Zahra Yari ◽

Azita Hekmatdoost ◽

Seyed Moayed Alavian ◽

Seyed Ali Keshavarz

Keyword(s):

Liver Disease ◽

Pilot Study ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Double Blind ◽

Nonalcoholic Fatty Liver ◽

Double Blind Placebo

Download Full-text

Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial

Annals of Hepatology ◽

10.1016/s1665-2681(19)32103-9 ◽

2004 ◽

Vol 3 (3) ◽

pp. 108-112 ◽

Cited By ~ 38

Author(s):

Nahum Méndez-Sánchez ◽

Verónica González ◽

Norberto Chávez-Tapia ◽

Martha H Ramos ◽

Misael Uribe

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Ursodeoxycholic Acid ◽

Nonalcoholic Fatty Liver Disease ◽

Weight Reduction ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Double Blind ◽

Nonalcoholic Fatty Liver ◽

Double Blind Placebo

Download Full-text

Effect of garlic powder consumption on body composition in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial

Advanced Biomedical Research ◽

10.4103/2277-9175.174962 ◽

2016 ◽

Vol 5 (1) ◽

pp. 2 ◽

Cited By ~ 16

Author(s):

Zamzam Paknahad ◽

Davood Soleimani ◽

Gholamreza Askari ◽

Bijan Iraj ◽

Awat Feizi

Keyword(s):

Body Composition ◽

Liver Disease ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Double Blind ◽

Nonalcoholic Fatty Liver ◽

Double Blind Placebo ◽

Powder Consumption

Download Full-text

Effects of Turmeric on Homocysteine and Fetuin-A in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Placebo-Controlled Study

Iranian Red Crescent Medical Journal ◽

10.5812/ircmj.43193 ◽

2017 ◽

Vol 19 (4) ◽

Cited By ~ 3

Author(s):

Aida Ghaffari ◽

Maryam Rafraf ◽

Roya Navekar ◽

Bita Sepehri ◽

Mohammad Asghari-Jafarabadi ◽

...

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Controlled Study ◽

Double Blind ◽

Fetuin A ◽

Nonalcoholic Fatty Liver ◽

Double Blind Placebo

Download Full-text

A CONSORT-Compliant, Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Purified Anthocyanin in Patients With Nonalcoholic Fatty Liver Disease

Medicine ◽

10.1097/md.0000000000000758 ◽

2015 ◽

Vol 94 (20) ◽

pp. e758 ◽

Cited By ~ 40

Author(s):

Pei-Wen Zhang ◽

Feng-Xia Chen ◽

Di Li ◽

Wen-Hua Ling ◽

Hong-Hui Guo

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Pilot Trial ◽

Double Blind ◽

Nonalcoholic Fatty Liver ◽

Double Blind Placebo

Download Full-text

Effects of Pharmacologic Dose of Resveratrol Supplementation on Oxidative/Antioxidative Status Biomarkers in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Advanced Pharmaceutical Bulletin ◽

10.15171/apb.2018.036 ◽

2018 ◽

Vol 8 (2) ◽

pp. 307-317 ◽

Cited By ~ 13

Author(s):

Somayyeh Asghari ◽

Maryam Rafraf ◽

Laleh Farzin ◽

Mohammad Asghari-Jafarabadi ◽

Seyed-Mostafa Ghavami ◽

...

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Double Blind ◽

Nonalcoholic Fatty Liver ◽

Double Blind Placebo ◽

Antioxidative Status

Download Full-text

Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease

Scientific Reports ◽

10.1038/s41598-019-42059-3 ◽

2019 ◽

Vol 9 (1) ◽

Cited By ~ 19

Author(s):

Sang Bong Ahn ◽

Dae Won Jun ◽

Bo-Kyeong Kang ◽

Jong Hyun Lim ◽

Sanghyun Lim ◽

...

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Controlled Study ◽

Double Blind ◽

Nonalcoholic Fatty Liver ◽

Double Blind Placebo

Download Full-text

Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial

Journal of Research in Medical Sciences ◽

10.4103/1735-1995.193178 ◽

2016 ◽

Vol 21 (1) ◽

pp. 106 ◽

Cited By ~ 8

Author(s):

Farzad Shidfar ◽

Golnaz Ekhlasi ◽

RoyaKolahdouz Mohammadi ◽

Shahram Agah ◽

Mitra Zarrati ◽

...

Keyword(s):

Liver Disease ◽

Vitamin E ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Double Blind ◽

Nonalcoholic Fatty Liver ◽

Double Blind Placebo ◽

Vitamin E Supplementation

Download Full-text

A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial

Journal of Trace Elements in Medicine and Biology ◽

10.1016/j.jtemb.2020.126659 ◽

2021 ◽

Vol 63 ◽

pp. 126659

Author(s):

Fardin Moradi ◽

Fateme Kooshki ◽

Forough Nokhostin ◽

Manouchehr Khoshbaten ◽

Hadi Bazyar ◽

...

Keyword(s):

Liver Disease ◽

Pilot Study ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Inflammatory Factors ◽

Chromium Picolinate ◽

Double Blind ◽

Nonalcoholic Fatty Liver ◽

Double Blind Placebo

Download Full-text

Inhibition of 11β‐hydroxysteroid dehydrogenase‐1 ( 11β‐HSD1 ) with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: a randomized, double‐blind, placebo‐controlled, phase II study

Diabetes Obesity and Metabolism ◽

10.1111/dom.14646 ◽

2022 ◽

Author(s):

Yogesh Yadav ◽

Kelly Dunagan ◽

Rachita Khot ◽

Sudhakar K. Venkatesh ◽

John Port ◽

...

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Nonalcoholic Fatty Liver Disease ◽

Nonalcoholic Steatohepatitis ◽

Fatty Liver Disease ◽

Phase Ii Study ◽

Hydroxysteroid Dehydrogenase ◽

Double Blind ◽

Nonalcoholic Fatty Liver ◽

Double Blind Placebo

Download Full-text